Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

shutterstock_273326141

Roche and Blueprint extend collaboration with $1.7 billion cancer drug development and commercialisation deal

July 14, 2020 Manufacturing and Production, Research and Development Blueprint Medicines, Cancer, Roche, pralsetinib

Roche and Blueprint Medicines have come together in a $1.7 billion development and commercialisation partnership focused on precision therapy pralsetinib …
News
pfizer_finland_hq_february_13_2009_1

Pfizer and BioNTech’s COVID-19 vaccines to have their development fast tracked by the FDA

July 14, 2020 Manufacturing and Production, Research and Development COVID-19, Vaccine, coronavirus

The FDA has granted Pfizer and BioNTech’s COVID-19 vaccine candidates Fast Track status to speed up their development and review. …
News
shutterstock_38078521

Itolizumab “significantly reduced mortality” in hospitalised COVID-19 patients with respiratory distress, secures emergency use authorisation in India

July 13, 2020 Research and Development, Sales and Marketing COVID-19, Itolizumab, coronavirus

Itolizumab, a drug currently being developed by biotech firm Equillium for autoimmune and inflammatory disorders, “significantly reduced mortality” in hospitalised …
News
tecentriq

Roche’s Tecentriq fails to hit main Phase 3 goal in front-line ovarian cancer

July 13, 2020 Research and Development, Sales and Marketing Genentech, Roche, ovarian cancer, tecentriq

Roche subsidiary Genentech has revealed that its immunotherapy Tecentriq (atezolizumab), combined with Avastin (bevacizumab), paclitaxel and carboplatin, fell short of …
News
edwin

Dr Edwin Moses appointed as Chairman of the Board of Sensorin

July 10, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Sensorin have appointed Dr Edwin Moses as the Chairman of its Board of Directors Moses joins from his previous role …
Appointment
shutterstock_159488225

New data shows Gilead’s remdesivir “potently inhibited” SARS-CoV-2 in human lung cell cultures

July 10, 2020 Medical Communications, Research and Development COVID-19, Gilead, coronavirus, remdesivir

New findings published from researchers at Vanderbilt University Medical Center (VUMC) at the University of North Carolina, as well as …
News
shutterstock_gonnorrhea

Industry comes together to form the AMR Action Fund, pledging $1bn to fight antimicrobial resistance

July 10, 2020 Medical Communications, Research and Development AMR, antimicrobial resistance, biotech, pharma

Over 20 biopharma firms have come together to launch the AMR Action Fund, an initiative of the International Federation of …
News
european_commission_web

European green light for Lynparza in germline BRCA-mutated metastatic pancreatic cancer

July 8, 2020 Research and Development, Sales and Marketing AstraZeneca, Cancer, Europe, MSD, lynparza

The European Commission has awarded approval to AstraZeneca and MSD’s Lynparza (olaparib) for germline BRCA-mutated (gBRCAm) metastatic pancreatic cancer, with …
News
shutterstock_3

COVID-19 impact on England’s cancer services could lead to 35,000 excess deaths

July 8, 2020 Research and Development COVID-19, Cancer, England, coronavirus

New data emerging from DATA-CAN: The Health Data Research Hub for Cancer has shone a light on the potential toll …
News
trummy

Trump moves to formally remove the US from the World Health Organization

July 8, 2020 Research and Development COVID-19, Trump, WHO

President Donald Trump has formally moved to end the US membership of the World Health Organization. He has notified both …
News
brazil

Brazilian President Jair Bolsonaro tests positive for COVID-19, says he is taking hydroxychloroquine

July 8, 2020 Research and Development Brazil, COVID-19, President of Brazil

Jair Bolsonaro, the President of Brazil, has tested positive for COVID-19 and says he treating the virus with hydroxychloroquine. The …
News
coroanrvisu_cdc

Pharmafile.com’s weekly COVID-19 news round-up

July 8, 2020 Research and Development

Coronavirus lockdowns and immunity feature in the news this week, with the UK Government accused of withholding Pillar 2 COVID-19 …
News
shutter

UK universities join forces for early-stage COVID-19 therapy testing platform

July 7, 2020 Manufacturing and Production, Research and Development COVID-19, UK, coronavirus

A coalition of UK universities have come together to build a new clinical trial and drug testing platform to evaluate …
News
european_commission_web

Europe extends Invokana indication to cover diabetic kidney disease in type 2 diabetes patients

July 3, 2020 Medical Communications, Research and Development Europe, Mundipharma, invokana

European Commission has moved to expand the existing approved indication for Mundipharma’s Invokana (canagliflozin), making it the first sodium glucose co-transporter …
News
vaccination-1215279_960_720

Promising early immunogenicity data for Pfizer and BioNTech’s COVID vaccine candidate

July 3, 2020 Medical Communications, Research and Development BioNTech, COVID-19, Pfizer, Vaccine

Pfizer and BioNTech have revealed new efficacy findings on the “most advanced” of four candidates being worked on as part …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026